| Literature DB >> 28428832 |
Michael E Scharf1, Yunpeng Cai2, Yijun Sun2, Ruchira Sen1, Rhitoban Raychoudhury1, Drion G Boucias3.
Abstract
The termite gut accomplishes key physiologic functions that underlie termite symbiosis and sociality. However, potential candidate functions of the host-symbiont holobiome have not yet been explored across seemingly divergent processes such as digestion, immunity, caste differentiation, and xenobiotic tolerance. This study took a meta-analysis approach for concurrently studying host and symbiont gut metatranscriptome responses of the lower termite Reticulitermes flavipes, which has ancestral characteristics and hosts a diverse mix of eukaryotic and bacterial symbionts. Thirteen treatments were compared from 5 categories (dietary, social, hormonal, immunological, and xenobiotic), revealing 3 main insights. First, each of the 5 tested colonies had distinct magnitudes of transcriptome response, likely as a result of unique symbiont profiles, which highlights the uniqueness of individual termite colonies. Second, after normalization to standardize colony response magnitudes, unique treatment-linked metatranscriptome topologies became apparent. Third, despite colony and topology differences, 4 co-opted master genes emerged that were universally responsive across diverse treatments. These master genes encode host functions related to protein translation and symbiont functions related to protein degradation and pore formation in microbial cell walls. Three of the 4 master genes were from co-evolved protist symbionts, highlighting potentially co-evolved roles for gut symbiota in coordinating functional responses of the collective host-symbiont holobiome. Lastly, for host genes identified, these results provide annotations of recent termite genome sequences. By revealing conserved domain genes, as well as apparent roles for gut symbiota in holobiome regulation, this study provides new insights into co-opted eusocial genes and symbiont roles in termite sociobiology.Entities:
Keywords: SPRY; TRMT; microbial ecology; microbiome; protist; septicolysin; social evolution; ubiquitin ligase
Year: 2017 PMID: 28428832 PMCID: PMC5390826 DOI: 10.1080/19420889.2017.1295187
Source DB: PubMed Journal: Commun Integr Biol ISSN: 1942-0889
Figure 1.Overview of treatments and experimental analyses. (A) Summary of all microarray treatments used in the present study for the 1st-tier topology analysis. (B) Summary of treatments selected for the 2nd-tier co-option analysis and the stepwise approach used. The goal of the topology analysis shown in A was to determine relationships of treatments to one another based on gene expression, while the goal of the analysis outlined in B to identify candidate master genes responsive across treatment categories. See panel A for treatment abbreviations shown in B.
Numbers of differentially expressed array positions at various significance levels when comparing each treatment with a mixed reference using different normalization strategies. *The column denoted by an asterisk indicates the normalization strategy and p-value cutoff used for co-option analyses.
| Non-normalized | Normalized by treatment or treatment category (identical results) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.01 level | 0.05 level | 0.01 level | 0.05 level | ||||||
| Treatment category | Treatment | P | Q | P | Q | P | Q | P* | Q |
| Nutritional | C | 1123 | 0 | 3386 | 29 | 1382 | 66 | 3287 | 446 |
| W | 235 | 0 | 1020 | 0 | 259 | 0 | 1116 | 0 | |
| Social | JH | 831 | 0 | 2374 | 17 | 901 | 1 | 2435 | 5 |
| LS | 195 | 4 | 942 | 14 | 213 | 0 | 975 | 18 | |
| A (control) | 249 | 1 | 906 | 20 | 216 | 0 | 853 | 0 | |
| SH | 139 | 0 | 530 | 0 | 146 | 0 | 547 | 0 | |
| LR | 114 | 0 | 495 | 0 | 111 | 0 | 481 | 0 | |
| Xenobiotic / Immunological | B+I | 2534 | 28 | 4768 | 1887 | 2764 | 5 | 4791 | 2508 |
| F+I | 1714 | 0 | 4133 | 425 | 2326 | 0 | 4405 | 1643 | |
| S (control) | 778 | 3 | 2096 | 22 | 697 | 0 | 2084 | 0 | |
| F | 259 | 1 | 1111 | 4 | 298 | 0 | 1141 | 0 | |
| I | 283 | 1 | 1115 | 29 | 297 | 0 | 1140 | 0 | |
| B | 217 | 3 | 993 | 15 | 244 | 0 | 1069 | 0 | |
Figure 2.Cluster analysis results showing significant colony effects that supersede treatment effects when non-normalized data are used. See Figure 1 for treatment abbreviations and details.
Figure 3.Topology profiles based on a Euclidian distance analyses of normalized microarray data. Top: A 3-dimensional plot of all data. Bottom: (a) control treatments, (b) diet/nutritional treatments, (c) hormonal/social treatments, (d) xenobiotic/immunological treatments. Abbreviations: S, DMSO solvent control; A, acetone control; C, cellulose paper; W, pine wood; JH, juvenile hormone; LS, live soldiers; SH, soldier head extract; LR, live reproductives; F, fungi; B, bacteria; I, imidacloprid; FI, fungi+imidacloprid; BI, bacteria+imidacloprid.
Figure 4.Identification of candidate co-opted genes. (A) Venn diagram showing numbers of shared passing genes in the nutrition-immunity (left) and hormonal-xenobiotic categories (right), and putative master genes shared among both categories (center), along with host or symbiont origins. See Fig. 1A for treatment abbreviations. (B) Identities and accession numbers of putative master genes along with fold change values across microarray treatments and controls relative to a common reference.